DUXAP8 and non-small cell lung carcinoma: determined that overexpression of DUXAP8 in NSCLC cells not only promotes cell proliferation and migration but was also related to the clinical grade and prognosis of NSCLC patients, and downregulation of DUXAP8 remarkably inhibited cell growth and migration (39).